Overriding TKI resistance of renal cell carcinoma by combination therapy with IL-6 receptor blockade.
Ishibashi K, Haber T, Breuksch I, Gebhard S, Sugino T, Kubo H, Hata J, Koguchi T, Yabe M, Kataoka M, Ogawa S, Hiraki H, Yanagida T, Haga N, Thüroff JW, Prawitt D, Brenner W, Kojima Y.
Ishibashi K, et al. Among authors: koguchi t.
Oncotarget. 2017 Jul 21;8(33):55230-55245. doi: 10.18632/oncotarget.19420. eCollection 2017 Aug 15.
Oncotarget. 2017.
PMID: 28903416
Free PMC article.